Finanzen von National Health Investors Inc (NHI)NHINational Health Investors Inc

National Health Investors, Inc. (NHI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Real Estate Investments, accounting for 63.1% of total sales, equivalent to $76.54M. Another important revenue stream is SHOP. Understanding this composition is critical for investors evaluating how NHI navigates market cycles within the Specialized REITs industry.

Evaluating the bottom line, National Health Investors, Inc. maintains a gross margin of 69.91%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 41.04%, while the net margin is 45.63%. These profitability ratios, combined with a Return on Equity (ROE) of 10.92%, provide a clear picture of how effectively NHI converts its operational activities into shareholder value.

In the context of the broader market, NHI competes directly with industry leaders such as CURB and HIW. With a market capitalization of $3.58B, it holds a leading position in the sector. When comparing efficiency, NHI's gross margin of 69.91% stands against CURB's 59.16% and HIW's 67.58%. Such benchmarking helps identify whether National Health Investors, Inc. is trading at a premium or discount relative to its financial performance.

National Health Investors has shown strong earnings growth, with an EPS of $1.15 in Q2 2026, a 45.6% increase year-over-year. The gross margin has decreased to 69.91%, but the company has maintained a healthy net margin of 45.63%.